Not applicableStudy completedNCT00900302What this trial is testingOX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With CancerWho this might be right forCancer OHSU Knight Cancer Institute 98
Testing effectiveness (Phase 2)Study completedNCT03114254What this trial is testingA Trial of Cabazitaxel Chemotherapy in Relapsed Locally Advanced &/or Metastatic Carcinoma of the PenisWho this might be right forPenile Neoplasm University Hospitals Bristol and Weston NHS Foundation Trust 17
Early research (Phase 1)Study completedNCT00019110What this trial is testingVaccine Therapy in Treating Patients With Advanced or Recurrent CancerWho this might be right forAnal CancerCervical CancerEsophageal Cancer+3 more National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07815197What this trial is testingSacituzumab Tirumotecan as Second-Line Treatment for Penile CancerWho this might be right forPenile Squamous Cell CarcinomaMetastatic Penile Squamous Cell Carcinoma Latin American Cooperative Oncology Group 37
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06505551What this trial is testingPhase 1/2 Study of Autologous SCG142 TCR T Cells in Patients With HPV16/52-positive CarcinomaWho this might be right forHPV-Related Squamous Cell CarcinomaHPV-Related Cervical Squamous Cell CarcinomaHPV-Related Vulvar Squamous Cell Carcinoma+4 more SCG Cell Therapy Pte. Ltd. 66
Early research (Phase 1)Study completedNCT00020579What this trial is testingMS-275 in Treating Patients With Advanced Solid Tumors or LymphomaWho this might be right forCancer National Institutes of Health Clinical Center (CC) 75
Testing effectiveness (Phase 2)Study completedNCT01728233What this trial is testingDacomitinib (PF-00299804) in Advanced/Metastatic Squamous Cell Carcinoma of the PenisWho this might be right forPenile NeoplasmsCarcinoma, Squamous Cell Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 32
Not applicableWithdrawnNCT04985357What this trial is testingDefining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to DrugsWho this might be right forStage III Breast CancerStage IV Breast CancerStage III Lung Cancer+35 more Travera Inc
Not applicableStudy completedNCT02104063What this trial is testingCharacterising Metastatic Penile Cancer Using Molecular Imaging - Hybrid MRI-PET [MRI-PET]Who this might be right forSquamous Cell Carcinoma of the Penis Queen Mary University of London 78
Not applicableStudy completedNCT03346915What this trial is testingIntegrating a Health Information Technology System for Primary and Secondary Cervical Cancer PreventionWho this might be right forHuman Papilloma VirusCervical CancerHuman Papillomavirus Infection+5 more Boston Medical Center 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT02721732What this trial is testingPembrolizumab in Treating Patients With Rare Tumors That Cannot Be Removed by Surgery or Are MetastaticWho this might be right forAdvanced Malignant Solid NeoplasmCarcinoma of Unknown PrimaryMetastatic Adrenal Gland Pheochromocytoma+16 more M.D. Anderson Cancer Center 157
Testing effectiveness (Phase 2)Study completedNCT00066391What this trial is testingIrinotecan and Cisplatin in Treating Patients With Locally Advanced or Metastatic Penile CancerWho this might be right forPenile Cancer European Organisation for Research and Treatment of Cancer - EORTC
Testing effectiveness (Phase 2)Study completedNCT02057913What this trial is testingA Phase II Trial of Vinflunine Chemotherapy in Locally-advanced and Metastatic Carcinoma of the Penis (VinCaP)Who this might be right forLocally-advanced or Metastatic Penile Neoplasms Institute of Cancer Research, United Kingdom 22
Testing effectiveness (Phase 2)Looking for participantsNCT03866382What this trial is testingTesting the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary TumorsWho this might be right forBladder AdenocarcinomaBladder Clear Cell AdenocarcinomaBladder Mixed Adenocarcinoma+42 more National Cancer Institute (NCI) 314
Early research (Phase 1)Active Not RecruitingNCT04491942What this trial is testingTesting the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial CancerWho this might be right forAdvanced Bile Duct CarcinomaAdvanced Breast CarcinomaAdvanced Cervical Carcinoma+31 more National Cancer Institute (NCI) 74
Not applicableStudy completedNCT04028479What this trial is testingThe Registry of Oncology Outcomes Associated With Testing and TreatmentWho this might be right forAdenocarcinomaAdenocystic CarcinomaAnal Cancer+73 more Taproot Health 167
Testing effectiveness (Phase 2)Ended earlyNCT00058448What this trial is testingS0224, Docetaxel in Treating Patients With Locally Advanced or Metastatic Penile Cancer (TERMINATED)Who this might be right forPenile Cancer SWOG Cancer Research Network 1
Large-scale testing (Phase 3)Study completedNCT00538850What this trial is testingFentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainWho this might be right forCancer INSYS Therapeutics Inc 130
Early research (Phase 1)Active Not RecruitingNCT05973487What this trial is testingA Basket Study of Customized Autologous TCR-T Cell Therapies in Patients With Locally Advanced (Unresectable) or Metastatic Solid TumorsWho this might be right forHead and Neck CancerCervical CancerNon-small Cell Carcinoma+18 more TScan Therapeutics, Inc. 840
Not applicableStudy completedNCT05887921What this trial is testingInguinal Lymphadenectomy for Penile CancerWho this might be right forPenile CancerLymph Node MetastasisSentinel Lymph Node+1 more A.O.U. Città della Salute e della Scienza 14